Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
The UK Intellectual Property Office (UKIPO) is consulting on possible changes to the UK design framework with the aims of improving design validity, simplifying the regime, and protecting emerging forms of design.
READ MORE
The G1/23 ruling from the European Patent Office marked a pivotal shift in how marketed products are treated as prior art, redefining the principles of reproducibility and disclosure across Europe. Dehns has collaborated with international patent experts to provide a global perspective on the ruling.
READ MORE
This decision concerned an application for provisional measures, in particular an anti-anti-suit injunction (‘AASI’), by Avago Technologies International Sales Pte. Limited against the defendant Realtek Semiconductor Corporation
READ MORE
Hosted by Philip Webber on 9 July 2020, this webinar covers what can be patented in the medical and biotech fields, and looks at some of the special requirements and rules that apply.
How did an iconic cafe on London’s North Circular get brand protection around the globe?
In the second of this two-part podcast on how to obtain a granted patent, we look at how patent attorneys can overcome objections from the Patent Office, and what happens if a 3rd party objects to your application.
In the first of a two-part podcast, we look at how to get a patent granted once an application has been filed.
How is a patent application examined? What should you do if an Examiner has any formal objections to your application; and how can you overcome these objections to improve your chances of obtaining legal protection for your innovation?
Hosted by Chris Goddard on 25 June 2020, this webinar is the first in a two part series covering Supplementary Protection Certificates.
In this episode we discuss the constituent parts of a formal patent application, and who does what as part of the process? Who can write an application, where do you submit it and what happens once you do submit it?
Brands are vital to any organisation operating in the food and beverage manufacturing business.
It’s no coincidence that many of the world’s most successful companies, with their highly recognisable trade marks, are found in the food and beverage sector
This episode of “The IP Podcast” looks at the actual ownership of an invention and who can claim the associated intellectual property rights, as it might not always be as straightforward as it seems.
This webinar covers patent claims, criteria for patentability and how to get patents granted.
In this, our first episode, we cover one of the earliest stages in the patent process: invention capture.
Subscribe here for updates on IP news, events and webinars.
|